Found: 39
Select item for more details and to access through your institution.
Outcomes for newly diagnosed patients with acute myeloid leukemia dosed on actual or adjusted body weight.
- Published in:
- 2015
- By:
- Publication type:
- journal article
High‐level MYC expression associates with poor survival in patients with acute myeloid leukemia and collaborates with overexpressed p53 in leukemic transformation in patients with myelodysplastic syndrome.
- Published in:
- International Journal of Laboratory Hematology, 2021, v. 43, n. 1, p. 99, doi. 10.1111/ijlh.13316
- By:
- Publication type:
- Article
An investigation of the interaction of carbonyl compounds with the snowpack.
- Published in:
- Geophysical Research Letters, 2000, v. 27, n. 15, p. 2241, doi. 10.1029/1999GL011288
- By:
- Publication type:
- Article
Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 3, p. 595, doi. 10.1111/bjh.15571
- By:
- Publication type:
- Article
Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 2, p. 228, doi. 10.1177/1078155214560920
- By:
- Publication type:
- Article
A novel hematopoietic progenitor cell mobilization regimen, utilizing bortezomib and filgrastim, for patients undergoing autologous transplant.
- Published in:
- Journal of Clinical Apheresis, 2016, v. 31, n. 6, p. 559, doi. 10.1002/jca.21449
- By:
- Publication type:
- Article
Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation.
- Published in:
- Journal of Clinical Apheresis, 2016, v. 31, n. 4, p. 347, doi. 10.1002/jca.21404
- By:
- Publication type:
- Article
Self-Renewal of Acute Lymphocytic Leukemia Cells Is Limited by the Hedgehog Pathway Inhibitors Cyclopamine and IPI-926.
- Published in:
- PLoS ONE, 2010, v. 5, n. 12, p. 1, doi. 10.1371/journal.pone.0015262
- By:
- Publication type:
- Article
Adjuvant therapy for resected non-small-cell lung cancer: Recent advances, emerging agents, and lingering questions.
- Published in:
- Current Oncology Reports, 2004, v. 6, n. 4, p. 251, doi. 10.1007/s11912-004-0032-3
- By:
- Publication type:
- Article
Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 11, p. 3049, doi. 10.1007/s00277-023-05442-9
- By:
- Publication type:
- Article
Long-term results of a pilot study evaluating hyperbaric oxygen therapy to improve umbilical cord blood engraftment.
- Published in:
- Annals of Hematology, 2019, v. 98, n. 2, p. 481, doi. 10.1007/s00277-018-3532-1
- By:
- Publication type:
- Article
Pulmonary manifestations of the pre-engraftment syndrome after umbilical cord blood transplantation.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 5, p. 847, doi. 10.1007/s00277-013-1981-0
- By:
- Publication type:
- Article
Quantifying the impact of the COVID-19 pandemic on cancer center clinical trial operations.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 4, p. 1, doi. 10.1093/jncics/pkad048
- By:
- Publication type:
- Article
Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5287, doi. 10.3390/cancers13215287
- By:
- Publication type:
- Article
A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4113, doi. 10.3390/cancers13164113
- By:
- Publication type:
- Article
A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 74, doi. 10.3390/cancers12010074
- By:
- Publication type:
- Article
Rates of complete diagnostic testing for patients with acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 4, p. 519, doi. 10.1002/cam4.406
- By:
- Publication type:
- Article
Post-hoc Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMA.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.806243
- By:
- Publication type:
- Article
The Glass Wall: Gendered Authorship Disparities in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. e344, doi. 10.1016/j.clml.2024.05.022
- By:
- Publication type:
- Article
A Phase 3 Study of CPX-351 versus Conventional 7+3 Cytarabine and Daunorubicin: Subanalysis of Patients with Secondary Acute Myeloid Leukemia (sAML) with Refractory Anemia with Excess of Blasts in Transformation (RAEB-t).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S208, doi. 10.1016/j.clml.2018.07.063
- By:
- Publication type:
- Article
Overall Survival (OS) and Stem Cell Transplant (SCT) in Patients with FLT3 Mutations Treated with CPX-351 versus 7+3: Subgroup Analysis of a Phase 3 Study of Older Adults with Newly Diagnosed, High-Risk Acute Myeloid Leukemia (AML).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S286, doi. 10.1016/j.clml.2017.07.071
- By:
- Publication type:
- Article
A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.
- Published in:
- 2021
- By:
- Publication type:
- Letter
High-Risk Microgranular Acute Promyelocytic Leukemia with a Five-Way Complex Translocation Involving PML-RARA.
- Published in:
- Case Reports in Hematology, 2015, v. 2015, p. 1, doi. 10.1155/2015/343854
- By:
- Publication type:
- Article
Skin Recurrence of Transformed Mycosis Fungoides Postumbilical Cord Blood Transplant despite Complete Donor Chimerism.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Bendamustine Associated with Irreversible Ascending Paralysis.
- Published in:
- Case Reports in Hematology, 2013, p. 1, doi. 10.1155/2013/931519
- By:
- Publication type:
- Article
Acute Myeloid Leukemia: Focus on Novel Therapeutic Strategies.
- Published in:
- Clinical Medicine Insights: Oncology, 2012, n. 6, p. 205, doi. 10.4137/CMO.S7244
- By:
- Publication type:
- Article
Acute Myeloid Leukemia: Focus on Novel Therapeutic Strategies.
- Published in:
- Clinical Medicine Insights: Oncology, 2012, n. 6, p. 205, doi. 10.4137/CMO.S7244
- By:
- Publication type:
- Article
Functional characterization of NPM1–TYK2 fusion oncogene.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00246-4
- By:
- Publication type:
- Article
Functional characterization of NPM1–TYK2 fusion oncogene.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00246-4
- By:
- Publication type:
- Article
Accelerating Cancer Patient Recruitment Through a Mobile Application (Clinical Trial Finder).
- Published in:
- Cancer Informatics, 2022, v. 21, p. 1, doi. 10.1177/11769351211073114
- By:
- Publication type:
- Article
A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 1, p. 79, doi. 10.1111/j.1365-2141.2012.09123.x
- By:
- Publication type:
- Article
Umbilical cord graft-versus-leukemia effect induces remission without the price of graft-versus-host disease: the possible role of NK cells.
- Published in:
- Clinical Transplantation, 2012, v. 26, n. 5, p. 663, doi. 10.1111/ctr.12006
- By:
- Publication type:
- Article
Hedgehog pathway as a drug target: Smoothened inhibitors in development.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 47, doi. 10.2147/OTT.S21957
- By:
- Publication type:
- Article
Utility of Routine Surveillance Imaging for Hodgkin Disease following Autologous Transplant: Experiences from a Single Institution.
- Published in:
- Acta Haematologica, 2018, v. 139, n. 1, p. 52, doi. 10.1159/000484549
- By:
- Publication type:
- Article
Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysis of a randomized, phase 3 trial.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01361-w
- By:
- Publication type:
- Article
Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01119-w
- By:
- Publication type:
- Article
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2308, doi. 10.1002/cncr.34780
- By:
- Publication type:
- Article
Accelerating Cancer Patient Recruitment Through a Mobile Application (Clinical Trial Finder).
- Published in:
- Cancer Informatics, 2022, v. 21, p. 1, doi. 10.1177/11769351211073114
- By:
- Publication type:
- Article